Item 2.02. Results of Operations and Financial Condition.
On October 28, 2021 we issued the press release furnished as Exhibit 99.1. The
press release describes the results of our operations for the quarter ended
September 30, 2021.
The information furnished in this Current Report on Form 8-K under Item 2.02 and
the attached exhibit shall not be deemed "filed" for purposes of Section 18 of
the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or
incorporated by reference in any filing under the Securities Act of 1933, as
amended, or the Exchange Act, except as shall be expressly set forth by specific
reference in such a filing.
Item 8.01. Other Events.
On October 28, 2021 we announced that our board of directors declared a
quarterly cash dividend of US $0.42 per share. The dividend will have a record
date of November 11, 2021, payable on December 16, 2021. The dividend will be
paid in U.S. currency to holders of ResMed's common stock trading on the New
York Stock Exchange. Holders of CHESS Depositary Instruments trading on the
Australian Securities Exchange will receive an equivalent amount in Australian
currency, based on the exchange rate on the record date, and reflecting the 10:1
ratio between CDIs and NYSE shares. The ex-dividend date will be November 10,
2021 for common stockholders and for CDI holders. ResMed has received a waiver
from the ASX's settlement operating rules, which will allow ResMed to defer
processing conversions between its common stock and CDI registers from
November 10, 2021 through November 11, 2021, inclusive.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibits: Description of Document
99.1 Press Release dated October 28, 2021 regarding results of
operations
104 Cover Page Interactive Data File (embedded within the Inline XBRL,
document)
-2-
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
RESMED, INC. 
